Page last updated: 2024-10-24

phosphatidylinositol phosphate binding

Definition

Target type: molecularfunction

Binding to phosphatidylinositol phosphate. [GOC:TermGenie, PMID:23445487]

Phosphatidylinositol phosphate (PIP) binding is a molecular function that describes the interaction of proteins with specific phosphoinositide lipids, particularly those containing phosphate groups at the 3-, 4-, or 5-positions of the inositol ring. These interactions are crucial for a wide range of cellular processes, including signal transduction, membrane trafficking, cytoskeletal organization, and regulation of enzyme activity.

PIPs act as signaling molecules, recruiting specific proteins to membranes and modulating their activity. The binding of PIPs to proteins is mediated by specialized domains, such as the pleckstrin homology (PH) domain, the FYVE domain, the PX domain, and the ENTH domain. These domains recognize and bind to specific PIPs through electrostatic interactions and hydrophobic contacts.

The specificity of PIP binding is determined by the number and position of phosphate groups on the inositol ring. For instance, the PH domain of phospholipase C-delta1 binds specifically to phosphatidylinositol 4,5-bisphosphate (PIP2), while the FYVE domain of early endosomal antigen 1 (EEA1) binds to phosphatidylinositol 3-phosphate (PI3P).

The binding of PIPs to proteins can have various functional consequences, including:

* **Recruitment to membranes:** PIPs act as docking sites for proteins, localizing them to specific membrane compartments. This is important for signaling pathways, where proteins need to be recruited to the plasma membrane or other organelles for activation.
* **Activation or inhibition of enzyme activity:** PIP binding can modulate the activity of enzymes by altering their conformation or by facilitating the recruitment of other regulatory proteins. For example, PIP2 binding to phospholipase C-delta1 activates its catalytic activity, leading to the production of diacylglycerol and inositol triphosphate.
* **Regulation of protein-protein interactions:** PIP binding can influence the interaction of proteins with other proteins, either by promoting or inhibiting their association. This is essential for the formation of signaling complexes and the coordination of cellular processes.
* **Membrane trafficking:** PIPs play a crucial role in the trafficking of vesicles and organelles within the cell. They provide signals for vesicle budding, movement, and fusion.
* **Cytoskeletal organization:** PIPs are involved in the regulation of the actin cytoskeleton, influencing cell shape, motility, and adhesion.

In conclusion, PIP binding is a fundamental molecular function that plays a critical role in a vast array of cellular processes. The specific PIPs recognized and the downstream consequences of their binding determine the diverse roles of these lipids in cellular signaling, membrane trafficking, and cytoskeletal organization.'
"

Proteins (1)

ProteinDefinitionTaxonomy
NACHT, LRR and PYD domains-containing protein 3 A NACHT, LRR and PYD domains-containing protein 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96P20]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
glyburideglyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
monochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
micheliolidemicheliolide: has antineoplastic activity; structure in first sourcesesquiterpene lactone
isoliquiritigeninchalconesantineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist
1,6-anhydro-3,4-dideoxy-beta-d-glycero-hex-3-enopyran-2-ulose1,6-anhydro-3,4-dideoxyhex-3-enopyran-2-ulose: structure in first sourceanhydrohexose;
deoxyketohexose
curcumincurcumin : A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa.

Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.
aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone: a cystic fibrosis transmembrane conductance regulator inhibitor; structure in first source
apigeninChamomile: Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia.trihydroxyflavoneantineoplastic agent;
metabolite
mcc-950